Skip to main content
Download PDF

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

Molecular Cancer volume 18, Article number: 122 (2019) Cite this article

The Original Article was published on 27 February 2017

Correction to: Mol Cancer (2017) 16:48

https://doi.org/10.1186/s12943-017-0615-x

After publication of the article [1], the author reported that this article contained some errors.

The photograph of sh-NC in Fig. 1c was misplaced. The correct version of the figure and the figure legend is presented below.

Fig. 1
figure 1

Prognostic value of miR-30d expression in PCa patients and its functions on tumor growth and angiogenesis in vivo using LNCaP cell induced tumor xenografts. a Kaplan-Meier analyses of biochemical recurrence (BCR)-free survival and overall survival of PCa patients based on miR- 30d expression in Taylor and TCGA datasets. b LNCaP cells stably expressing miR-30d formed significantly larger tumor nodules and remarkably speeded up tumor xenografts growth compared with the controls. Conversely, PCa cells that permanently suppressed miR-30d expression led to the smaller tumor nodules and the slower tumor growth compared with the control. c Immunohistochemical analysis using pan-endothelial marker CD31 antibody. d VEGFA protein expression in different groups detected by Western blot analysis. Data were presented as Mean ± SD. *P < 0.05. **P < 0.01

Full size image

Reference

  1. Lin Z-y, Chen G, Zhang Y-q, He H-c, Liang Y-x, Ye J-h, Liang Y-k, Mo R-j, Jian-ming L, Zhuo Y-j, Zheng Y, Jiang F-n, Han Z-d, Shu-lin W, Zhong W-d, Chin-Lee W. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer. 2017;16:48. https://doi.org/10.1186/s12943-017-0615-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang and Hui-chan He contributed equally to this work.

Authors and Affiliations

  1. Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, 510180, China

    Zhuo-yuan Lin, Guo Chen, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Fu-neng Jiang, Zhao-dong Han, Wei-de Zhong & Chin-Lee Wu

  2. Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510260, China

    Zhuo-yuan Lin & Yu Zheng

  3. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China

    Yan-qiong Zhang

  4. Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China

    Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng & Wei-de Zhong

  5. Urology Key Laboratory of Guangdong Province, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510230, China

    Wei-de Zhong

  6. Graduate school of Jinan University, Guangzhou, 510632, China

    Wei-de Zhong

  7. Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    Yan-qiong Zhang, Jian-heng Ye, Shu-lin Wu & Chin-Lee Wu

  8. Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    Yan-qiong Zhang, Jian-heng Ye, Shu-lin Wu & Chin-Lee Wu

Authors
  1. Zhuo-yuan Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guo Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan-qiong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hui-chan He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-xiang Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jian-heng Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ying-ke Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ru-jun Mo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jian-ming Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yang-jia Zhuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yu Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Fu-neng Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Zhao-dong Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Shu-lin Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Wei-de Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Chin-Lee Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Wei-de Zhong or Chin-Lee Wu.

Additional information

The article to which this update relates has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1186/s12943-023-01763-5

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, Zy., Chen, G., Zhang, Yq. et al. Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer 18, 122 (2019). https://doi.org/10.1186/s12943-019-1051-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12943-019-1051-x

Molecular Cancer

ISSN: 1476-4598